Drug Shortage Report for APO-DICLO SR

Last updated on 2024-11-22 History
Report ID 241685
Drug Identification Number 02162814
Brand name APO-DICLO SR
Common or Proper name DICLOFENAC SR
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DICLOFENAC SODIUM
Strength(s) 75MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-29
Estimated end date 2024-11-22
Actual end date 2024-11-21
Shortage status Resolved
Updated date 2024-11-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-10-31 English Compare
v2 2024-10-31 French Compare
v3 2024-11-14 English Compare
v4 2024-11-14 French Compare
v5 2024-11-22 English Compare
v6 2024-11-22 French Compare

Showing 1 to 6 of 6